Abstract
Blastomycosis is the least understood of the major endemic mycoses in North America. The fungus exists in the soil in its mycelial form, and when the proper growth conditions exist growth and spore formation will occur. When microfici containing the growing mycelium of blastomyces are disturbed, an infecting aerosol is formed. The spores are inhaled and eventually settle in the alveoli where multiplication by binary fission occurs. Following development of cell-mediated immunity the infection is localized in the lung. During the pre-immune phase of the infection spread to extrapulmonary sites may occur. Most common sites of involvement include the skin, bones, prostate and central nervous system. Pulmonary disease may resolve spontaneously or progress. Treatment is required for progressive pulmonary illness and all episodes of extrapulmonary disease. For life-threatening blastomycosis or blastomycosis of the central nervous system amphotericin B is the treatment of choice, while ketoconazole is an excellent alternative for patients who are not critically ill or have no central nervous system involvement.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gilchrist, T. C. Protozoan dermatitis. Journal of Cutaneous and Genitourinary Diseases 1894, 12: 496–499.
Gilchrist, T. C., Stokes, W. R. Case of pseudolupus vulgaris caused by blastomycosis. Journal of Experimental Medicine 1898, 3: 53–78.
Hektoen, L. Systemic blastomycosis and coccodioidal granuloma. Journal of the American Medical Association 1907, 49: 1070–1077.
Montgomery, F. H., Ormsby, O. S. Systemic blastomycosis. Archives of Internal Medicine 1908, 2: 1–41.
Martin, D. S., Smith, D. T. Blastomycosis. II: A report of thirteen new cases. American Review of Tuberculosis 1939, 39: 488–515.
Schwarz, J., Baum, G. L. Blastomycosis. American Journal of Clinical Pathology 1951, 11: 999–1029.
Sarosi, G. A., Davies, S. F. Blastomycosis: state of the art. American Review of Respiratory Diseases 1979, 120: 911–938.
Furcolow, M. L., Chick, E. W., Busey, J. D., Menges, R. W. Prevalence and incidence studies of human and canine blastomycosis. I: Cases in the United States 1895–1968. American Review of Respiratory Diseases 1970, 102: 60–67.
Kepron, M. D., Schoemperlen, B., Hershfield, E. S. Zylak, C. I., Cherniak, R. M. North American blastomycosis in central Canada. Canadian Medical Association Journal 1972, 106: 243–246.
Klein, B. S., Vergeront, J. M., Weeks, R. J., Nanda Kumar, U., Mathai, G., Varkey, B., Kaufman, L., Bradsher, W., Stoebing, J. F., Davis, J. P., and theInvestigation Team Isolation ofBlastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. New England Journal of Medicine 1986, 314: 529–534.
Goodwin, R. A., DesPrez, R. M. Histoplasmosis: state of the art. American Review of Respiratory Diseases 1978, 117: 929–946.
Baum, G. L., Lerner, P. I. Primary pulmonary blastomycosis: a laboratory acquired infection. Annals of Internal Medicine 1970, 73: 263–265.
Sarosi, G. A., Hammerman, K. J., Tosh, F. E., Kroenberg, R. S. Clinical features of acute pulmonary blastomycosis. New England Journal of Medicine 1974, 290: 540–543.
Miller, D. D. Davies, S. F., Sarosi, G. A. Erythema nodosum and blastomycosis. Archives of Internal Medicine 1982, 142: 1839.
Laskey, W. L., Sarosi, G. A. The radiologic appearance of pulmonary blastomycosis. Radiology 1978, 126: 351–357.
Laskey, W. L., Sarosi, G. A. Endogenous reactivation in blastomycosis. Annals of Internal Medicine 1978, 88: 50–52.
Witorsch, P., Utz, J. P. North American blastomycosis. A study of 40 patients. Medicine 1968, 47: 169–200.
Davies, S. F., Sarosi, G. A. Role of serodiagnostic tests and skin tests in diagnosis of fungal diseases. Clinics in Chest Medicine 1987, 8: 135–146.
Klein, B. S., Kuritsky, J. N., Chappell, W. A., Kaufman, L., Green, J., Davies, S. F., Williams, J. E., Sarosi, G. A. Comparison of the enzyme immunoassay, immunodiffusion and complement fixation tests in detecting antibody in human serum to the A antigen ofBlastomyces dermatitidis. American Review of Respiratory Diseases 1986, 133: 144–148.
Sanders, J. S., Sarosi, G. A., Nollett, D. J., Thompson, J. I. Exfoliative cytology in the rapid diagnosis of pulmonary blastomycosis. Chest 1977, 72: 193–196.
Sarosi, G. A., Davies, S. F., Phillips, J. R. Self-limited blastomycosis: a report of 39 cases. Seminars in Respiratory Infections 1986, 1: 40–44.
Dismukes, W. E., Stamm, A. M., Graybill, J. R., Craven, P. C., Stevens, D. A., Stiller, R. L., Sarosi, G. A., Medoff, G., Gregg, C. R., Gallis, H. A., Fields, B. T., Marier, R. L., Kerkering, T. A., Kaplowitz, L. G., Cloud, G., Bowles, C., Shadomy, S. Treatment of systemic mycoses with ketoconazole; emphasis on toxicity and clinical response in 52 patients. Annals of Internal Medicine 1983, 98: 13–20.
Mycoses Study Group Treatment of blastomycosis and histoplasmosis with ketoconazole. Annals of Internal Medicine 1985, 103: 861–872.
Bradsher, R. W., Rice, D. C., Abernathy, R. S. Ketoconazole therapy for endemic blastomycosis. Annals of Internal Medicine 1985, 103: 872–879.
Kravitz, G. E., Davies, S. F., Eckman, M. R., Sarosi, G. A. Chronic blastomycotic meningitis. American Journal of Medicine 1981, 71: 501–505.
Dismukes, W. E. Azole antifungal drugs: old and new. Annals of Internal Medicine 1988, 109: 177–179.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davies, S.F., Sarosi, G.A. Blastomycosis. Eur. J. Clin. Microbiol. Infect. Dis. 8, 474–479 (1989). https://doi.org/10.1007/BF01964062
Issue Date:
DOI: https://doi.org/10.1007/BF01964062